The digital therapeutics market is witnessing considerable growth globally thanks to the confluence of the development of new technologies, the increasing prevalence of chronic diseases and lifestyle-associated diseases and an aging population. Exactly how the technology will impact the health care milieu was the subject of a panel held at the Biotechnology Innovation Organization's 2019 international convention earlier this month, organized by Accel-Rx, Canada's health sciences accelerator that supports promising early stage companies developing therapeutics, diagnostics and medical devices.